Plaintiffs win class certification in US antitrust case over Tracleer
MLex Summary: An employee health fund won class certification in a US case against Actelion Pharmaceuticals over delayed entry of a generic version of its hypertension drug Tracleer. The proposed class...To view the full article, register now.
Already a subscriber? Click here to view full article